Share This Article

Facebook LinkedIn
Twitter Reddit
Print Email
Pinterest Gmail
Yahoo
Money Morning
×
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • AI Investing
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
  • Retire
    • Income Investing Guide
    • Retirement Articles
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    • Postcards
Login Archives Your Team About Us FAQ
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • AI Investing
    ×
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
    ×
  • Retire
    • Income Investing Guide
    • Retirement Articles
    ×
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    • Postcards
    ×
  • Subscribe
Enter stock ticker or keyword
×
Join 100,000+ Like-Minded Investors Today
Twitter
Tags: Dow Jones
Stocks: BA, GE, GILD

The Dow Jones Rallies After Gilead Drug Shows Promise in Treating COVID-19

By Garrett Baldwin, Executive Producer, Money Morning • April 17, 2020

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Garrett BaldwinGarrett Baldwin

The Dow Jones popped this morning on news that a drug from Gilead Sciences Inc. (NASDAQ: GILD) showed some effectiveness in treating patients with the coronavirus.

Shares of the drug company surged 16% after the bell on a report from a Chicago hospital that showed progress from Remdesivir. More on this below.

First, here are the numbers from Thursday for the Dow, S&P 500, and Nasdaq:

Index Previous Close Point Change Percentage Change
Dow Jones 23,537.68 +33.33 +0.14
S&P 500 2,799.55 +16.19 +0.58
Nasdaq 8,532.36 +139.19 +1.66

Now let's take a look at what I consider to be the most important market events to start your day.

The Top Stock Market Stories for Friday

  • Johns Hopkins University announced that the number of cases around the world has topped 2 million, with more than 650,000 in the United States alone. The number of cases continues to expand across southern states like Louisiana and Georgia. Meanwhile, China's National Health Commission announced that its official death toll had increased by more than 35%.

The Best Stocks to Buy Now: 2020's market free fall has been gut-wrenching, but there's a silver lining: It's opening up a chance to get into great stocks at low prices we might never see again in our lifetime. Click here...

  • We've been paying close attention to March economic data from the United States, but today's highlights center on China. This morning, China announced that its economy shrank by 6.8% in the first quarter as the country dealt with the spread of coronavirus. Beijing had engaged in a large shutdown of its economy to reduce human contact and the spread of the virus. This was the first time that the Chinese economy contracted in Q1 since 1992.
  • Remdesivir has shown progress in other treatment studies; however, the question is whether it can help reduce investors' anxiety about the surging U.S. unemployment situation. A treatment would likely provide a better path to reopening the U.S. economy sooner than the time it would take to develop a vaccine. The treatment doesn't require universal transmission because it will only require usage among infected people.

Stocks to Watch Today: BA, GE, F, GM, PG

  • Shares of Boeing Inc. (NYSE: BA) rallied 7% on news that the aircraft manufacturer plans to reopen production in the Seattle area by April 20. The firm announced it will implement a string of physical distancing standards to prevent the spread of the coronavirus.
  • Shares of General Electric Co. (NYSE: GE), Ford Motor Co. (NYSE: F), and General Motors Co. (NYSE: GM) all jumped after they signed contracts with the U.S. government to produce tens of thousands of ventilators. General Electric is working with Ford on a plan to produce 50,000 units. GM will work with Ventec Life Systems to produce 30,000 ventilators.
  • Shares of Proctor & Gamble Co. (NYSE: PG) are on the rise this morning after the firm reported strong earnings expectations. The company benefited from the rush of consumers stocking up on staples ahead of the social distancing requirements.

The New Rules for Buying Low and Selling High in Today's Market

If you want to buy low and sell high in today's market, there's only one rule you need to follow.

Today, Tom Gentile is sharing everything - including the exact formula that could magnify your profits faster than you could ever believe.

Take a look.

Follow Money Morning on Facebook and Twitter.

Here Are 10 “One-Click” Ways to Earn 10% or Better on Your Money Every Quarter

Appreciation is great, but it’s possible to get even more out of the shares you own. A lot more: you can easily beat inflation and collect regular income to spare. There are no complicated trades to put on, no high-level options clearances necessary. In fact, you can do this with a couple of mouse clicks – passive income redefined. Click here for the report…

Claim My Free Report

Garrett BaldwinGarrett Baldwin

About the Author

Browse Garrett's articles |

Garrett Baldwin is a globally recognized research economist, financial writer, consultant, and political risk analyst with decades of trading experience and degrees in economics, cybersecurity, and business from Johns Hopkins, Purdue, Indiana University, and Northwestern.

… Read full bio

Subscribe
Login
Notify of
guest

guest

0 Comments
Inline Feedbacks
View all comments


Latest News

September 22, 2023 • By Shah Gilani

earnings
Why the Fed's "Higher for Longer" Message on Interest Rates is Bogus

September 22, 2023 • By Tom Gentile

This is the Top 'Worst-in-Breed' Stock Heading into October

September 21, 2023 • By Shah Gilani

earnings
The Best Auto Stocks to Buy (or Avoid) Right Now
Trending Stories
ABOUT MONEY MORNING

Money Morning gives you access to a team of market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

QUICK LINKS
About Us COVID-19 Announcements How Money Morning Works FAQs Contact Us Search Article Archive Forgot Username/Password Archives Profit Academy Research Your Team Videos Text Messaging Terms of Use
FREE NEWSLETTERS
Total Wealth Research Power Profit Trades Penny Hawk Midday Momentum
PREMIUM SERVICES
Money Map Press Home Money Map Report Fast Fortune Club Weekly Cash Clock Microcurrency Trader Hyperdrive Portfolio Rocket Wealth Initiative Quantum Data Profits Flashpoint Trader Darknet Alpha Accelerators Brutus Alerts Resource Traders Alliance L.A.U.N.C.H. Investor Rob Roy Trader Long-Term Equity Profits

© 2023 Money Morning All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning.

Address: 1125 N Charles St. | Baltimore, MD, 21201 | USA | Phone: 888.384.8339 | Disclaimer | Sitemap | Privacy Policy | Whitelist Us | Do Not Sell or Share My Personal Information

wpDiscuz